Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Smith & Nephew Plc
  6. Summary
    SN.   GB0009223206

SMITH & NEPHEW PLC

(SN.)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
06/09/2021 06/10/2021 06/11/2021 06/14/2021 06/15/2021 Date
1506(c) 1542.5(c) 1546(c) 1549.5(c) 1552.1889 Last
2 701 742 2 546 997 1 191 016 1 063 658 179 871 Volume
+2.28% +2.42% +0.23% +0.23% +0.17% Change
More quotes
Financials (USD)
Sales 2021 5 335 M - -
Net income 2021 462 M - -
Net Debt 2021 1 841 M - -
P/E ratio 2021 42,2x
Yield 2021 1,77%
Sales 2022 5 675 M - -
Net income 2022 698 M - -
Net Debt 2022 1 698 M - -
P/E ratio 2022 27,5x
Yield 2022 2,02%
Capitalization 19 193 M 19 195 M -
EV / Sales 2021 3,94x
EV / Sales 2022 3,68x
Nbr of Employees 17 914
Free-Float 98,7%
More Financials
Company
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows: - orthopedic surgery (42.1%): primarily orthopedic implants (hips, knees and shoulders) ; - sports medicine, arthroscopy and cervicofacial surgery (29.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound... 
Read more
More about the company
Ratings of Smith & Nephew Plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about SMITH & NEPHEW PLC
06/10European ADRs Move Higher in Thursday Trading
MT
06/09European ADRs Slightly Higher Wednesday With Biotechs Leading While Miners Dr..
MT
06/09SMITH & NEPHEW  : Upgraded by Credit Suisse to Outperform From Neutral, Price Ta..
MT
06/09SMITH & NEPHEW  : Credit Suisse Lifts Smith & Nephew To Outperform From Neutral,..
MT
06/09British shares end lower as mining, financial stocks weigh
RE
06/03European ADRs Move Lower in Thursday Trading
MT
06/01SMITH & NEPHEW  : Commission pursuant to Rule 12g3-2 (b) under the Securities Ex..
PU
05/28European ADRs Move Higher in Friday Trading
MT
05/27SMITH & NEPHEW  : JPMorgan Lifts Smith & Nephew PT, Affirms Neutral Rating
MT
05/25SMITH & NEPHEW  : Commission pursuant to Rule 12g3-2 (b) under the Securities Ex..
PU
05/21SMITH & NEPHEW  : Commission pursuant to Rule 12g3-2 (b) under the Securities Ex..
PU
05/18DETAILS OF THE TRANSACTION(S) : section to be repeated for (i) each type of inst..
PU
05/12SMITH & NEPHEW  : Commission pursuant to Rule 12g3-2 (b) under the Securities Ex..
PU
05/11SMITH & NEPHEW  : Investor presentation April - June 2021
PU
05/06SMITH & NEPHEW  : +Nephew launches ARIA Home PT - a remote physical therapy solu..
AQ
More news
News in other languages on SMITH & NEPHEW PLC
06/09SMITH & NEPHEW  : Credit Suisse relève son opinion
04/15STOCK MARKET PARIS : Des entreprises gonflées à bloc
04/15AVIS D'ANALYSTES DU JOUR  : EDF, LVMH, Accor, Eurofins, Virbac, Shop Apotheke, J..
02/11ROLAND DIGGELMANN : Sonova gibt neuen CFO und Veränderungen im Verwaltungsrat be..
2020SMITH & NEPHEW PLC  : prudent vis-à-vis du coronavirus
More news
Analyst Recommendations on SMITH & NEPHEW PLC
More recommendations
Chart SMITH & NEPHEW PLC
Duration : Period :
Smith & Nephew Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SMITH & NEPHEW PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 23,50 $
Last Close Price 21,86 $
Spread / Highest target 27,6%
Spread / Average Target 7,51%
Spread / Lowest Target -9,14%
EPS Revisions
Managers and Directors
NameTitle
Roland D. Diggelmann Chief Executive Officer & Non-Executive Director
Anne-Francoise Nesmes Chief Financial Officer & Executive Director
Roberto Quarta Chairman
Vasant Padmanabhan President-Research & Development
Mark Gladwell President-Global Operations & Business Services
Sector and Competitors
1st jan.Capitalization (M$)
SMITH & NEPHEW PLC2.62%19 195
STRYKER CORPORATION4.35%96 368
INSPIRE MEDICAL SYSTEMS, INC.0.11%4 983
VENUS MEDTECH (HANGZHOU) INC.-8.79%4 097
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.40.14%3 960
GLAUKOS CORPORATION7.03%3 696